Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
1M
6M
1Y
3Y
All
NAV: 14 Oct 2025
₹20.75
Rating
2
Min. SIP amount
₹100
Fund size
₹162.74Cr
Return calculator
Monthly SIP
One-Time
₹5,000 per month
Over the past
Total investment of ₹0
Would have become ₹ (%)
Holdings (45)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 10.89% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 6.17% |
Cipla Ltd. | Healthcare | Equity | 6.05% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.31% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 5.25% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 5.09% |
Divi's Laboratories Ltd. | Healthcare | Equity | 4.84% |
Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 3.80% |
AbbVie Inc | Healthcare | Forgn. Eq | 3.49% |
Fortis Healthcare Ltd. | Healthcare | Equity | 3.39% |
Lupin Ltd. | Healthcare | Equity | 3.11% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.04% |
Mankind Pharma Ltd. | Healthcare | Equity | 2.15% |
Laurus Labs Ltd. | Healthcare | Equity | 2.10% |
Novartis AG | Healthcare | ADS/ADR | 2.08% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 2.02% |
Abbott Laboratories | Healthcare | Forgn. Eq | 1.99% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 1.96% |
Merck & Co Inc (US) | Healthcare | Forgn. Eq | 1.80% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 1.76% |
Alkem Laboratories Ltd. | Healthcare | Equity | 1.62% |
Thermo Fisher Scientific Inc. | Healthcare | Forgn. Eq | 1.56% |
Novo Nordisk A/S - ADR | Healthcare | ADS/ADR | 1.52% |
Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 1.37% |
Ipca Laboratories Ltd. | Healthcare | Equity | 1.33% |
Biocon Ltd. | Healthcare | Equity | 1.30% |
Amgen Inc. (USA) | Healthcare | Forgn. Eq | 1.29% |
Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 1.18% |
Danaher Corporation | Healthcare | Forgn. Eq | 1.09% |
Stryker Corp | Healthcare | Forgn. Eq | 1.09% |
Gland Pharma Ltd. | Healthcare | Equity | 1.05% |
Medtronic | Healthcare | Forgn. Eq | 1.04% |
Narayana Hrudayalaya Ltd. | Healthcare | Equity | 0.88% |
Vertex Pharmaceuticals Inc. (USA) | Healthcare | Forgn. Eq | 0.86% |
Piramal Pharma Ltd. | Healthcare | Equity | 0.81% |
Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 0.80% |
Syngene International Ltd. | Healthcare | Equity | 0.80% |
Ajanta Pharma Ltd. | Healthcare | Equity | 0.75% |
Global Health Ltd. | Healthcare | Equity | 0.75% |
Cohance Lifesciences Ltd. | Healthcare | Equity | 0.72% |
Regeneron Pharmaceuticals Inc | Healthcare | Forgn. Eq | 0.51% |
Becton Dickinson And Co | Healthcare | Forgn. Eq | 0.46% |
Agilent Technologies Inc | Healthcare | Forgn. Eq | 0.31% |
Iqvia Holdings | Healthcare | Forgn. Eq | 0.28% |
Illumina Inc. (USA) | Healthcare | Forgn. Eq | 0.13% |
See All
Minimum investment amounts
| Min. for 1st investment | Not Supported |
| Min. for 2nd investment onwards | Not Supported |
| Min. for SIP | ₹100 |
Returns and rankings
Category: Equity Sectoral
Annualised returns
Absolute returns
| 6M | 1Y | 3Y | All | |
|---|---|---|---|---|
| Fund returns | NA | -0.6% | 19.6% | 15.8% |
| Category average | NA | -1.8% | 22.3% | NA |
| Rank with in category | NA | 10 | 11 | NA |
Understand terms
Expense ratio, exit load and tax
Expense ratio: 0.52%
Inclusive of GST
Exit load
Nil
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Understand terms
Check past data
Fund management
Bhavesh JainOct 2021 - PresentView details
Bhavesh Jain
Oct 2021 - Present
View details
Education
Mr. Jain is a MMS (Finance) from Mumbai University.
Experience
Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.
Also manages these schemes
Amit VoraFeb 2021 - PresentView details
Amit Vora
Feb 2021 - Present
View details
Education
Mr. Vora has done B.Com from University of Mumbai
Experience
Antique Stock Broking Ltd, D.E. Shaw India Securities Pvt. Ltd, Derivium Tradition Securities (India) Pvt Ltd, Tower Capital & Securities Pvt Ltd and B&K Securities
Also manages these schemes
Fund house & investment objective
Fund house contact details
Address
Edelweiss HouseOff C.S.T. Road,Kalina Mumbai 400098
Phone
+91 22 4093 3400
Launch Date
30 Apr 2008
E-mail
NAWebsite
www.edelweissmf.com
Edelweiss Mutual Fund
Asset Management Company
Custodian
Standard Chartered Bank
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,
Email
[email protected]Website
www.karvymfs.comPros and cons
Category: Equity Sectoral
Pros
Exit load is zero
1Y annualised returns higher than category average by 1.89%
Cons
3Y annualised returns lower than category average by 2.49%
Higher expense ratio: 0.52%
Low rating: 2
Compare funds
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
VS
Add mutual fund to compare